<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Actos</title><link>http://www.unboundmedicine.com/medline/ebm/research/Actos</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob/ob mice.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19038243/full_citation/The_dipeptidyl_peptidase_4_inhibitor_alogliptin_in_combination_with_pioglitazone_improves_glycemic_control_lipid_profiles_and_increases_pancreatic_insulin_content_in_ob/ob_mice_</link><description>Moritoh Y, Takeuchi K, Asakawa T, et al. <br/><span class="title">The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob/ob mice. [JOURNAL ARTICLE]</span><br/><span class="source" title="European journal of pharmacology">Eur J Pharmacol 2008 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19038243/abstract/The_dipeptidyl_peptidase_4_inhibitor_alogliptin_in_combination_with_pioglitazone_improves_glycemic_control_lipid_profiles_and_increases_pancreatic_insulin_content_in_ob/ob_mice_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19038243/full_citation/The_dipeptidyl_peptidase_4_inhibitor_alogliptin_in_combination_with_pioglitazone_improves_glycemic_control_lipid_profiles_and_increases_pancreatic_insulin_content_in_ob/ob_mice_">Full Citation</a></description></item><item><title>Type 2 deiodinase expression is induced by PPAR-{gamma} agonists in skeletal myocytes.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19036883/full_citation/Type_2_deiodinase_expression_is_induced_by_PPAR_{gamma}_agonists_in_skeletal_myocytes_</link><description>Grozovsky R, Ribich S, Rosene ML, et al. <br/><span class="title">Type 2 deiodinase expression is induced by PPAR-{gamma} agonists in skeletal myocytes. [JOURNAL ARTICLE]</span><br/><span class="source" title="Endocrinology">Endocrinology 2008 Nov 26.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19036883/abstract/Type_2_deiodinase_expression_is_induced_by_PPAR_{gamma}_agonists_in_skeletal_myocytes_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19036883/full_citation/Type_2_deiodinase_expression_is_induced_by_PPAR_{gamma}_agonists_in_skeletal_myocytes_">Full Citation</a> | <a href="http://endo.endojournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=19036883">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19036883/Type_2_deiodinase_expression_is_induced_by_PPAR_{gamma}_agonists_in_skeletal_myocytes_">Find Related Articles</a> </description></item><item><title>Cardiovascular risk and cardiometabolic protection: role of glitazones.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19034866/full_citation/Cardiovascular_risk_and_cardiometabolic_protection:_role_of_glitazones_</link><description>Petrazzi L, Grassi D, Polidoro L, et al. <br/><span class="title">Cardiovascular risk and cardiometabolic protection: role of glitazones. [Journal Article]</span><br/><span class="source" title="Journal of nephrology">J Nephrol 2008 Nov-Dec; 21(6):826-35.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19034866/abstract/Cardiovascular_risk_and_cardiometabolic_protection:_role_of_glitazones_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19034866/full_citation/Cardiovascular_risk_and_cardiometabolic_protection:_role_of_glitazones_">Full Citation</a></description></item><item><title>Fenofibrate and Pioglitazone Do Not Ameliorate the Altered Vascular Reactivity in Aorta of Isoproterenol-treated Rats.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19033820/full_citation/Fenofibrate_and_Pioglitazone_Do_Not_Ameliorate_the_Altered_Vascular_Reactivity_in_Aorta_of_Isoproterenol_treated_Rats_</link><description>Fukuda LE, Davel AP, Verissimo-Filho S, et al. <br/><span class="title">Fenofibrate and Pioglitazone Do Not Ameliorate the Altered Vascular Reactivity in Aorta of Isoproterenol-treated Rats. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of cardiovascular pharmacology">J Cardiovasc Pharmacol 2008 Nov; 52(5):413-421.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19033820/abstract/Fenofibrate_and_Pioglitazone_Do_Not_Ameliorate_the_Altered_Vascular_Reactivity_in_Aorta_of_Isoproterenol_treated_Rats_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19033820/full_citation/Fenofibrate_and_Pioglitazone_Do_Not_Ameliorate_the_Altered_Vascular_Reactivity_in_Aorta_of_Isoproterenol_treated_Rats_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19033820/Fenofibrate_and_Pioglitazone_Do_Not_Ameliorate_the_Altered_Vascular_Reactivity_in_Aorta_of_Isoproterenol_treated_Rats_">Find Related Articles</a> </description></item><item><title>Molecular Mechanisms of Alcoholic Fatty Liver.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19032584/full_citation/Molecular_Mechanisms_of_Alcoholic_Fatty_Liver_</link><description>Purohit V, Gao B, Song BJ <br/><span class="title">Molecular Mechanisms of Alcoholic Fatty Liver. [JOURNAL ARTICLE]</span><br/><span class="source" title="Alcoholism, clinical and experimental research">Alcohol Clin Exp Res 2008 Nov 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19032584/abstract/Molecular_Mechanisms_of_Alcoholic_Fatty_Liver_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19032584/full_citation/Molecular_Mechanisms_of_Alcoholic_Fatty_Liver_">Full Citation</a></description></item><item><title>Comparison of cardiovascular outcomes in elderly patients with diabetes who initiated rosiglitazone vs pioglitazone therapy.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19029503/full_citation/Comparison_of_cardiovascular_outcomes_in_elderly_patients_with_diabetes_who_initiated_rosiglitazone_vs_pioglitazone_therapy_</link><description>Winkelmayer WC, Setoguchi S, Levin R, et al. <br/><span class="title">Comparison of cardiovascular outcomes in elderly patients with diabetes who initiated rosiglitazone vs pioglitazone therapy. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Archives of internal medicine">Arch Intern Med 2008 Nov 24; 168(21):2368-75.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19029503/abstract/Comparison_of_cardiovascular_outcomes_in_elderly_patients_with_diabetes_who_initiated_rosiglitazone_vs_pioglitazone_therapy_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19029503/full_citation/Comparison_of_cardiovascular_outcomes_in_elderly_patients_with_diabetes_who_initiated_rosiglitazone_vs_pioglitazone_therapy_">Full Citation</a> | <a href="http://archinte.ama-assn.org/cgi/pmidlookup%3fview=long%26amp;pmid=19029503">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19029503/Comparison_of_cardiovascular_outcomes_in_elderly_patients_with_diabetes_who_initiated_rosiglitazone_vs_pioglitazone_therapy_">Find Related Articles</a> </description></item><item><title>Low-dose pioglitazone and low-dose flutamide added to metformin and estro-progestagens for hyperinsulinemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19018783/full_citation/Low_dose_pioglitazone_and_low_dose_flutamide_added_to_metformin_and_estro_progestagens_for_hyperinsulinemic_women_with_androgen_excess:_add_on_benefits_disclosed_by_a_randomized_double_placebo_study_over_24_months_</link><description>Ibáñez L, López-Bermejo A, Díaz M, et al. <br/><span class="title">Low-dose pioglitazone and low-dose flutamide added to metformin and estro-progestagens for hyperinsulinemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical endocrinology">Clin Endocrinol (Oxf) 2008 Nov 5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19018783/abstract/Low_dose_pioglitazone_and_low_dose_flutamide_added_to_metformin_and_estro_progestagens_for_hyperinsulinemic_women_with_androgen_excess:_add_on_benefits_disclosed_by_a_randomized_double_placebo_study_over_24_months_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19018783/full_citation/Low_dose_pioglitazone_and_low_dose_flutamide_added_to_metformin_and_estro_progestagens_for_hyperinsulinemic_women_with_androgen_excess:_add_on_benefits_disclosed_by_a_randomized_double_placebo_study_over_24_months_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19018783/Low_dose_pioglitazone_and_low_dose_flutamide_added_to_metformin_and_estro_progestagens_for_hyperinsulinemic_women_with_androgen_excess:_add_on_benefits_disclosed_by_a_randomized_double_placebo_study_over_24_months_">Find Related Articles</a> </description></item><item><title>Pioglitazone Attenuates Tactile Allodynia and Thermal Hyperalgesia in Mice Subjected to Peripheral Nerve Injury.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19008646/full_citation/Pioglitazone_Attenuates_Tactile_Allodynia_and_Thermal_Hyperalgesia_in_Mice_Subjected_to_Peripheral_Nerve_Injury_</link><description>Maeda T, Kiguchi N, Kobayashi Y, et al. <br/><span class="title">Pioglitazone Attenuates Tactile Allodynia and Thermal Hyperalgesia in Mice Subjected to Peripheral Nerve Injury. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of pharmacological sciences">J Pharmacol Sci 2008 Nov 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19008646/abstract/Pioglitazone_Attenuates_Tactile_Allodynia_and_Thermal_Hyperalgesia_in_Mice_Subjected_to_Peripheral_Nerve_Injury_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19008646/full_citation/Pioglitazone_Attenuates_Tactile_Allodynia_and_Thermal_Hyperalgesia_in_Mice_Subjected_to_Peripheral_Nerve_Injury_">Full Citation</a></description></item><item><title>Adrenomedullin Improves Cardiac Expression of Heat-Shock Protein 72 and Tolerance against Ischemia/Reperfusion Injury in Insulin-Resistant Rats.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19008310/full_citation/Adrenomedullin_Improves_Cardiac_Expression_of_Heat_Shock_Protein_72_and_Tolerance_against_Ischemia/Reperfusion_Injury_in_Insulin_Resistant_Rats_</link><description>Torigoe Y, Takahashi N, Hara M, et al. <br/><span class="title">Adrenomedullin Improves Cardiac Expression of Heat-Shock Protein 72 and Tolerance against Ischemia/Reperfusion Injury in Insulin-Resistant Rats. [JOURNAL ARTICLE]</span><br/><span class="source" title="Endocrinology">Endocrinology 2008 Nov 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19008310/abstract/Adrenomedullin_Improves_Cardiac_Expression_of_Heat_Shock_Protein_72_and_Tolerance_against_Ischemia/Reperfusion_Injury_in_Insulin_Resistant_Rats_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19008310/full_citation/Adrenomedullin_Improves_Cardiac_Expression_of_Heat_Shock_Protein_72_and_Tolerance_against_Ischemia/Reperfusion_Injury_in_Insulin_Resistant_Rats_">Full Citation</a> | <a href="http://endo.endojournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=19008310">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19008310/Adrenomedullin_Improves_Cardiac_Expression_of_Heat_Shock_Protein_72_and_Tolerance_against_Ischemia/Reperfusion_Injury_in_Insulin_Resistant_Rats_">Find Related Articles</a> </description></item><item><title>Development and validation of a simple and rapid HPLC method for determination of pioglitazone in human plasma and its application to a pharmacokinetic study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19007483/full_citation/Development_and_validation_of_a_simple_and_rapid_HPLC_method_for_determination_of_pioglitazone_in_human_plasma_and_its_application_to_a_pharmacokinetic_study_</link><description>Souri E, Jalalizadeh H, Saremi S <br/><span class="title">Development and validation of a simple and rapid HPLC method for determination of pioglitazone in human plasma and its application to a pharmacokinetic study. [Journal Article]</span><br/><span class="source" title="Journal of chromatographic science">J Chromatogr Sci 2008 Oct; 46(9):809-12.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19007483/abstract/Development_and_validation_of_a_simple_and_rapid_HPLC_method_for_determination_of_pioglitazone_in_human_plasma_and_its_application_to_a_pharmacokinetic_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19007483/full_citation/Development_and_validation_of_a_simple_and_rapid_HPLC_method_for_determination_of_pioglitazone_in_human_plasma_and_its_application_to_a_pharmacokinetic_study_">Full Citation</a></description></item></channel></rss>